Abstract:Emerging evidence suggests that accumulation of oxidative DNA damage in nuclear genome is an important contributing factor in neuronal cell death after cerebral ischemia. It has been shown in various models of cerebral ischemia/reperfusion that there is accumulation of oxidative DNA base damage and apurinic/apyridinic abasic site (AP site) in injured neurons, which could mediate neuronal degeneration by triggering various pro-apoptotic molecules. In the brain most types of oxidative DNA damage are repaired via the base-excision repair (BER) pathway that is highly inducible in response to various sublethal stimuli. Thus, interventions that enhance the activity of the BER pathway may be a potential therapeutic strategy against ischemic cell death. In the present study, we have examined the neuroprotective effect of the neuropeptide pituitary adenylate cyclase activating polypeptide (PACAP) in the rat model of transient global cerebral ischemia. Further, we have investigated the role of BER regulation as a potential mechanism underlying the effect of PACAP. PACAP, when infused intracerebroventricularly in the rat, potently protected against CA1 neuronal cell death after global cerebral ischemia produced by 12 minutes of 4-vessel occlusion. Associated with this neuroprotection, PACAP treatment reduced the accumulation of oxidative DNA lesions, especially AP site, and subsequently attenuated the activation of pro-apoptotic molecules p53 and PUMA in the CA1 sector, suggesting that the effect of PACAP may involve the acceleration of the repair process of endogenous oxidative DNA damage. To investigate the underlying mechanism, cellular BER activity and the expression of BER enzymes were measured in the hippocampal extracts. The results revealed that PACAP markedly enhanced the hippocampal expression (at both mRNA and protein levels) and activities of the essential BER enzymes AP endonuclase (APE) and DNA polymerase-beta. Furthermore, based on the results of inhibition studies, the inducible effect of PACAP on the BER pathway was found to be dependent on the phosphorylation and nuclear translocation of cAMP-response-element-binding protein (CREB), which mediated the enhanced transcription of both APE and DNA polymerase-beta. Finally, the effect of PACAP on BER and neuroprotection was mimicked by the administration of a cAMP/protein kinase A (PKA) agonist. The results of the present study demonstrate the neuroprotective effect of PACAP in hippocampal CA1 neurons after transient global cerebral ischemia. The effect of PACAP is dependent on the activation and nuclear translocation of CREB, and involves CREB-mediated activation of BER pathway for endogenous DNA repair. The results suggest that enhancement of neuronal DNA repair capacity by PACAP or other means may be a novel potential therapeutic approach to limit ischemic neuronal loss. (This project was supported by NIH grants NS36736, NS38560, NS 43802, and NS45048).

EXPERIMENTAL STUDY OF PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE ON RELIEVING BRAIN EDEMA INDUCED BY ISCHEMIA IN RATS

Pituitary Adenylate Cyclase-Activating Polypeptide Attenuates Brain Edema by Protecting Blood–Brain Barrier and Glymphatic System After Subarachnoid Hemorrhage in Rats

[Study of the Effects of Auricularia Auricular Polysaccharide on Local Ischemia/reperfusion Injury in Rat].

Propofol Pretreatment Attenuates Aquaporin-4 Over-Expression and Alleviates Cerebral Edema after Transient Focal Brain Ischemia Reperfusion in Rats

Neuropeptide Pacap in Mouse Liver Ischemia and Reperfusion Injury: Immunomodulation by the Camp-Pka Pathway

Pituitary adenylate cyclase-activating polypeptide attenuates mitochondria-mediated oxidative stress and neuronal apoptosis after subarachnoid hemorrhage in rats

PACAP38 Differentially Effects Genes and CRMP2 Protein Expression in Ischemic Core and Penumbra Regions of Permanent Middle Cerebral Artery Occlusion Model Mice Brain

Neuroprotection against ischemic CA1 neurodegeneration by pituitary adenylate cyclase activating polypeptide via cAMP-response-element-binding protein-mediated enhancement of endogenous DNA repair

Neuroprotective effects of neurokinin1 receptor antagonist on cerebral ischemia-reperfusion in rats

Pituitary Adenylate Cyclase-Activating Polypeptide Protects Against Cognitive Impairment Caused by Chronic Cerebral Hypoperfusion

Pituitary Adenylate Cyclase-Activating Polypeptide: A Promising Neuroprotective Peptide in Stroke

Pituitary Adenylate Cyclase Activating Polypeptide Elicits Neuroprotection Against Acute Ischemic Neuronal Cell Death Associated with NMDA Receptors

PACAP glycosides promote cell outgrowth in vitro and reduce infarct size after stroke in a preclinical model

Expressions of endogenous pituitary adenylate cyclase-activating polypeptide following acute spinal cord injury in rats

Intracerebroventricular injection of human prostatic acid phosphatase has potent neuroprotective effects against transient focal cerebral ischemia in rats.

Edaravone Attenuates Brain Edema and Injury by Down-Regulating Expressions of P38 Mitogen-Activated Protein Kinase and Aquaporin-4 after Focal Cerebral Ischemia and Reperfusion in Mice

Pituitary Adenylate Cyclase Activating-Peptide and Its Receptor Antagonists in Development of Acute Pancreatitis in Rats.

Protective Effects of Pituitary Adenylate-Cyclase-Activating Polypeptide on Retinal Vasculature and Molecular Responses in a Rat Model of Moderate Glaucoma

Pituitary Adenylate Cyclase Activating Polypeptide Attenuates the Neurotoxicity Mediated by Nitric Oxide

Activation of the Epac/Rap1 signaling pathway alleviates blood-brain barrier disruption and brain damage following cerebral ischemia/reperfusion injury

Impact Assessment of Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) and Hemostatic Sponge on Vascular Anastomosis Regeneration in Rats